Empowerment program for managing Type 2 Diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on providing education and empowerment techniques to patients with Type 2 Diabetes through a structured program at the Center for Comprehensive Care of Patients with Diabetes (CAIPaDi). The program includes four monthly visits followed by ongoing support via internet or cell phone technology. It aims to improve self-care activities and achieve international treatment standards over a two-year period. The study will measure the program's impact on various health parameters, including HbA1c levels and blood pressure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* being over 18 and under 70 years old
* having diagnosis of type 2 diabetes in the five previous years,
* having family support
* free of disabling diabetes complications

Exclusion Criteria:

* advanced complications of diabetes, such as ischemic heart disease, heart failure NYHA III-IV, KDOQI ≥3 renal failure, amputations, cerebral vascular disease, gastroparesis and muscular atrophy .
* type 1 diabetes mellitus, gestational diabetes or some variant of diabetes related to genetic syndromes, hyperlabile diabetes
* co-morbidities that limit their life expectancy such as malignant tumors
* advanced cognitive impairment or serious psychiatric disorders
* smoking, alcoholism or illegal drug dependence
* conditions that require surgical treatment in the short run or which prevent moderated activity.

Where it's running

• Instituto Nacional de Ciencias Medicas y Nutricion
  Mexico City, Mexico City, Mexico Recruiting

Study contacts

• Principal investigator: Sergio C Hernández, MD — National Institute of Medical Sciences and Nutrition Salvador Zubirán
• Study coordinator: Sergio Hernández, MD
• Email: sergiohdzj@hotmail.com
• Phone: 57870900

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.